Biomarkers and Antibodies Development for Glioblastoma - Creative Biolabs

Glioblastoma (GBM) represents 16% of all primary malignant brain tumors and nervous system neoplasms in adults. It is the most frequent and dangerous primary brain tumor. Necrosis and endothelial growth are its histopathologic characteristics, which led to the World Health Organization (WHO) assigning it the highest rating (grade IV) among brain tumors.